Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Figures from Mergermarket show the value of transactions jumped 370% in 2018

Seen and heard: PwC to review children’s hospital costs, ESB may offload Dublin depot

Inflazome in one of the largest European biotech fundraisings this year as it targets range of serious inflammatory diseases

After several false starts, way is clear for John Thero to take Vascepa cholesterol drug to market

Irish healthcare venture capital group Fountain among backers of HRT alternative

Group completes back pain neurostimulator implants in all 204 patients enrolled in test for device

Galway medical device firm developing rhinitis cure device for use in doctors’ offices

Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer

Fountain Healthcare participates in €17m funding round for Syndesi Therapeutics

Irish medtech start-up seeking to commercialise non-invasive device for condition

Dublin-listed medical devices firm recently made its first commercial sale in Germany

Sale of Neuravi is largest deal for a venture-backed medtech in Europe since 2009

Iseq-listed medical device firm targets commercial growth and completion of US clinical trials

Dublin-listed firm pushes ahead with plans to commercialise back pain treatment

Company’s flagship product ReActiv8 won European approval earlier this year

Chrono Therapeutics developing device to deliver nicotine through skin in timed doses

Start-up’s technology allows surgeons to finish heart surgery without leaving stitches

Operating expenses also decline while R&D and clinical and regulatory costs rise

Firm developing products to treat postoperative pain and diabetic foot infections

Irish company has won European approval of neurostimulator to treat chronic lower back pain and targeting US market

Nine of top 10 pharmaceutical firms in the world located here

US biopharma group Spark Therapeutics buys Dublin-based Trinity spin-out Genable Technologies

New approach to alleviating chronic back pain

A trial of 47 patients showed after three months, 63 per cent reported clinically important improvement in back pain

Elan executives turn their sights to funding side of biotech/life sciences business

Group targeting European investments in specialty pharma, biotech, medical devices and diagnostics

Alkermes spinoff also delivers dividend for drug technology group

Proceeds will fund clinical trials of back pain device as shares float at lower end of guided range

Irish back pain group hopes to raise €20m to fund clinical trials and other costs of bringing device to market

Mainstay Medical looking to list in Paris and Dublin as it trials first product

Genable Technologies will licence certain intellectual property from Spark under deal

Three years to get a product to trials

Implanted Reactiv8 unit designed to stabilise spinal muscles with electrical impulses

Trinity College spin-out will initially target mild to moderate ulcerative colitis